These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 31206637)

  • 1. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
    Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).
    Fong PY; Tan SH; Lim DWT; Tan EH; Ng QS; Sommat K; Tan DSW; Ang MK
    PLoS One; 2019; 14(11):e0224665. PubMed ID: 31747406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
    Dyckhoff G; Plinkert PK; Ramroth H
    BMC Cancer; 2017 Sep; 17(1):609. PubMed ID: 28863776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative-dose Chemoradiotherapy Versus Total Laryngectomy For Stage T3-T4 Squamous Cell Carcinoma of the Larynx: An "Apples-to-Apples" Analysis of the National Cancer Database.
    Bates JE; Amdur RJ; Morris CM; Hitchcock KE; Dziegielewski PT; Boyce BJ; Silver NL; Shaw C; Mendenhall WM
    Am J Clin Oncol; 2019 Jun; 42(6):527-533. PubMed ID: 31136370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.
    Bonner J; Giralt J; Harari P; Spencer S; Schulten J; Hossain A; Chang SC; Chin S; Baselga J
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):842-9. PubMed ID: 27389475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced hypopharyngeal and laryngeal cancer: Influence of HPV status.
    Bates JE; Morris CG; Hitchcock KE; Dziegielewski PT; Mendenhall WM; Amdur RJ
    Radiother Oncol; 2019 Nov; 140():6-9. PubMed ID: 31174105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function.
    Nobacht A; Meijer TWH; Oosting SF; van der Vegt B; Wedman J; Halmos GB; Plaat BEC
    J Laryngol Otol; 2024 Jun; 138(6):672-678. PubMed ID: 38235588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of 849 laryngeal cancers treated in the past 40 years: are we succeeding?
    Nakayama M; Okamoto M; Hayakawa K; Miyamoto S; Ishiyama H; Komori S; Okamoto T; Seino Y; Kano K; Soda I; Sekiguchi A; Kawakami S
    Jpn J Clin Oncol; 2014 Jan; 44(1):57-64. PubMed ID: 24174633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancer.
    Wick CC; Rezaee RP; Wang T; Garcia-Jarchow AM; Zender CA; Gibson M; Yao M; Lavertu P
    Am J Otolaryngol; 2017; 38(1):72-76. PubMed ID: 27838151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
    Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
    Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
    Choi YS; Park SG; Song EK; Cho SH; Park MR; Park KU; Lee KH; Song IC; Lee HJ; Jo DY; Kim S; Yun HJ;
    Head Neck; 2016 Aug; 38(8):1271-7. PubMed ID: 27043228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
    Al-Mamgani A; Navran A; Walraven I; Schreuder WH; Tesselaar MET; Klop WMC
    Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):575-583. PubMed ID: 30564952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subglottic squamous cell carcinoma in Denmark 1971-2015 - a national population-based cohort study from DAHANCA, the Danish Head and Neck Cancer group.
    Hill-Madsen L; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Primdahl H; Overgaard J; Lyhne NM
    Acta Oncol; 2019 Oct; 58(10):1509-1513. PubMed ID: 31364888
    [No Abstract]   [Full Text] [Related]  

  • 16. Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer.
    Petersen JF; Arends CR; van der Noort V; Al-Mamgani A; de Boer JP; Stuiver MM; van den Brekel MWM
    Oral Oncol; 2019 Aug; 95():143-149. PubMed ID: 31345382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma.
    Beyaert S; Hamoir M; Van Maanen A; Grégoire V; Schmitz S
    Eur J Surg Oncol; 2019 Jul; 45(7):1188-1195. PubMed ID: 30940421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
    Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
    Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival.
    Dziegielewski PT; O'Connell DA; Klein M; Fung C; Singh P; Alex Mlynarek M; Fung D; Harris JR; Seikaly H
    J Otolaryngol Head Neck Surg; 2012 Apr; 41 Suppl 1():S56-64. PubMed ID: 22569051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
    Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.